Recent research has demonstrated that a lot of information about a cancer can be elucidated from a formalin-fixed sample, as opposed to having to use a fresh or frozen sample, as was previously the case when investigating tumor DNA. In this interview, recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK, Andrew Beggs, FRCS (Gen), PhD, of the University of Birmingham, Birmingham, UK, discusses why these formalin-based advancements are so important, and why they will bring great benefits to laboratories and hospitals throughout the country.
Importance of formalin-fixed samples
